Claritev Agrees With Lantern To Enhance Surgical Cost Transparency And Positively Impact Care Quality And Cost Savings

Benzinga·05/07/2025 12:03:31

Listen to the news

The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint.

Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a powerful solution for healthcare cost optimization that ultimately lowers costs in the healthcare ecosystem.

This collaboration builds upon previous joint research, enabling Claritev and Lantern to provide enhanced value to employers, as well as the healthcare services that patients receive through data-driven surgical cost analysis and healthcare cost optimization.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English